Platelet factor 4 improved disease measures in SOD1 ALS mice
Original source
A Blood-Derived Factor Rescues ALS: Platelet Factor 4 Activates OPTN-Dependent Autophagy to Clear SOD1 Aggregates Independently of PINK1. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human, Mouse
Population inferred from the title and abstract by Compass.
A study identified platelet factor 4 (PF4) as a blood-derived factor linked to amyotrophic lateral sclerosis (ALS) risk and tested it as a treatment in mice. Giving recombinant PF4 improved survival and motor function in mice with SOD1-driven ALS, while reducing neuroinflammation and nerve-muscle connection loss. The reported effects were not observed in TDP-43 or C9orf72 ALS mouse models.
Why this matters
PF4 may be a candidate biomarker or treatment target for SOD1-related ALS. However, this was an animal study, and it does not currently change treatment for people with ALS. The findings may be less relevant to ALS driven by other disease mechanisms.
Limitations and context
The source describes primary research in mice and a population study, not a human treatment trial. The reported benefits were limited to SOD1-driven models and were absent in the TDP-43 and C9orf72 models tested. The source does not establish whether PF4 is safe or effective in people with ALS, or whether it benefits people with sporadic ALS or other genetic forms.